Constarium
← Search

Omics · study · 2026

Therapeutic HPV16 E7 Vaccination with CD137 Agonism Induces Tumour Regression and Durable Immunity in Mice

Listed in NCBI GEO

Therapeutic HPV16 E7 vaccination was evaluated in the syngeneic TC-1 tumour model in female C57BL/6 mice.

Description

Bulk RNA sequencing was performed on pooled, non-adherent mononuclear cell-enriched fractions prepared from subcutaneous tumour samples. The dataset compares PBS or vehicle controls, MPLA-adjuvanted wild-type E7 vaccination, MPLA-adjuvanted recombinant overlapping peptide E7 (ROP-E7) vaccination, anti-CD137 (4-1BB) agonism, and ROP-E7 plus anti-CD137 combination therapy.

The study was designed to characterise treatment-associated changes in tumour immune and stromal transcriptional signatures.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34703112 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title